RxDoctor Payments DataLook up a doctor →

William Hixson, MD

Radiation Oncology · Fairhope, ALNPI 1932183217

Payments from drug & device makers

$9,799in general payments, 2019–2025

Across 505 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • AstraZeneca$899
  • Merck$609
  • Johnson & Johnson$595
  • Regeneron Healthcare Solutions, Inc.$552
  • Incyte Corporation$434
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$9,785100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis51$1,016
AstraZeneca(2 entities)54$899
Merck31$609
Johnson & Johnson(2 entities)33$595
Regeneron Healthcare Solutions, Inc.21$552
Incyte Corporation23$434
Lilly USA, LLC24$428
Eisai Inc.21$387
Amgen23$367
E.r. Squibb & Sons, L.L.C.16$272
Daiichi Sankyo Inc.10$239
Exelixis Inc.12$230
AbbVie10$230
Blueprint Medicines Corporation9$223
Sanofi10$223
Genentech USA, Inc.10$179
Bayer9$175
Pharmacosmos Therapeutics Inc.7$170
Seagen Inc.9$162
Pfizer9$161
Pharmaessentia USA Corporation6$146
Astellas Pharma US Inc7$145
Stemline Therapeutics Inc.6$127
Boston Scientific1$125
Takeda Pharmaceuticals U.S.A., Inc.5$119
Boehringer Ingelheim4$95
GSK5$85
Novocure Inc.4$84
Sumitomo Pharma America, Inc.5$81
AVEO Pharmaceuticals, Inc.5$76
Genmab U.S., Inc.4$72
Beigene USA, Inc.4$66
Tempus AI, Inc4$63
Progenics Pharmaceuticals, Inc.3$58
GE HealthCare1$56
Myovant Sciences Inc.4$54
Beone Medicines USA, Inc.3$51
Pharmacyclics LLC, An Abbvie Company2$47
Apellis Pharmaceuticals, Inc.3$42
Adaptive Biotechnologies Corporation2$40
Agios Pharmaceuticals, Inc.2$38
Sobi, Inc2$38
Ipsen Biopharmaceuticals, Inc2$37
Bristol Myers Squibb2$37
Puma Biotechnology, Inc.2$36
Dendreon Pharmaceuticals LLC1$35
Immunogen, Inc.2$34
Mirati Therapeutics, Inc.2$33
Coherus Oncology, Inc.2$32
Myriad Genetic Laboratories, Inc.2$30
Servier Pharmaceuticals LLC2$28
Sun Pharmaceutical Industries Inc.1$23
Pharming Healthcare, Inc.1$23
Karyopharm Therapeutics Inc.1$21
Springworks Therapeutics, Inc.1$21
Caris MPI, Inc.1$21
Paratek Pharmaceuticals, Inc.1$19
Array Biopharma Inc1$19
Azurity Pharmaceuticals, Inc.1$18
TG Therapeutics, Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,799 in reported general payments places this provider in the 85th percentile of 87 radiation oncology providers in Alabama.

See all radiation oncology providers in Alabama

Medicare billing

Part B allowed, 2024
$283,683
Medicare patients
76
Services billed
1,453

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl82$1,175
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$151

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Fairhope

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →